Delivery Order SPE2DB22D3016-SPE2DB25FAHR4

Award Date 12/30/24
Potential Completion Date 1/22/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHR4
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S for the Defense Logistics Agency (DLA). The firm-fixed-price contract has a ceiling value of $7,492.44 and a period of performance through January 22, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to supply a comprehensive range of medical products to support military healthcare programs globally. In addition, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.

Generated 3/31/25, 9:37 AM